2nd Quarter - Report

ILLUMINA, INC. for ILLUMINA, INC.

Firm
Client
Income
—
Expenses
$270,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General Discussions related to the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests General Discussions related to Medicaid coverage of Whole Genome Sequencing (WGS) H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests

LobbyistCovered position, as disclosed
NICOLAS MAGALLANES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2407 (118th)

Trade (domestic/foreign) TRD

H.R. 8333: BIOSECURE Act; provisions related to technical issues pertaining to genomics regulation

LobbyistCovered position, as disclosed
NICOLAS MAGALLANES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8333 (118th)

Defense DEF

H.R. 8070: Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; provisions related to genomics issues pertaining to national security

LobbyistCovered position, as disclosed
NICOLAS MAGALLANES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8070 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.